Your browser doesn't support javascript.
loading
Tocilizumab versus anakinra in COVID-19: results from propensity score matching.
Arcani, Robin; Correard, Florian; Suchon, Pierre; Kaplanski, Gilles; Jean, Rodolphe; Cauchois, Raphael; Leprince, Marine; Arcani, Vincent; Seguier, Julie; De Sainte Marie, Benjamin; Andre, Baptiste; Koubi, Marie; Rossi, Pascal; Gayet, Stéphane; Gobin, Nirvina; Garrido, Victoria; Weiland, Joris; Jouve, Elisabeth; Couderc, Anne-Laure; Villani, Patrick; Daumas, Aurélie.
Afiliação
  • Arcani R; Internal Medicine and Therapeutics Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Correard F; Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France.
  • Suchon P; Pharmacy Department, CHU La Timone, AP-HM, Marseille, France.
  • Kaplanski G; Hematology Laboratory, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Jean R; Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France.
  • Cauchois R; Internal Medicine and Clinical Immunology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Leprince M; Internal Medicine and Clinical Immunology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Arcani V; Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France.
  • Seguier J; Internal Medicine and Clinical Immunology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • De Sainte Marie B; Internal Medicine and Clinical Immunology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Andre B; Pharmacy Department, CHU La Timone, AP-HM, Marseille, France.
  • Koubi M; Internal Medicine Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Rossi P; Internal Medicine Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Gayet S; Internal Medicine Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Gobin N; Department of Internal Medicine, CHU Nord, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Garrido V; Department of Internal Medicine, CHU Nord, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Weiland J; Internal Medicine and Therapeutics Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Jouve E; Internal Medicine and Therapeutics Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Couderc AL; Internal Medicine and Therapeutics Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Villani P; Internal Medicine and Therapeutics Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Daumas A; Service Evaluation Médicale, CHU la Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
Front Immunol ; 14: 1185716, 2023.
Article em En | MEDLINE | ID: mdl-37304271

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article